CND Life Sciences

CND Life Sciences

Private
Scottsdale, ArizonaHealthcare & Life Scienceshttps://cndlifesciences.com

Last Round

Grant

Oct 22, 2025

Total Funding Raised

$23.4M

Momentum Score

25 /100

Company Overview

CND Life Sciences is a biotechnology company that provides a diagnostic test to aid in the confirmation of synucleinopathies like Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Medical AI, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

synucleinopathy diagnosisParkinson's disease diagnosisskin biopsy testParkinson's testalpha-synuclein detectionsynuclein testlaboratory-developed testLDTAI-assisted diagnosisneurology diagnosticsclinical trial supportbiopharmaceutical servicesdementia with Lewy bodiesmultiple system atrophybiomarker analysisCLIA-certified lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CND Life Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CND Life Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantOct 22, 2025
Series A ExtensionMay 1, 2025
SeedApr 6, 2023
SeedMar 23, 2021

Key People

Founding team and executive leadership

Christopher Gibbons

Chief Science Officer, Co-Founder

Founding Team

Rick Morello

Chief Executive Officer

Executive Team

CND Life Sciences Investors

Notable investors and investment history

InvestorRounds
VILAS VenturesSeries A Extension
Top Corner CapitalSeries A Extension, Seed
NIH RADxGrant
Cambrian Growth PartnersSeries A Extension
Tanis VenturesSeries A Extension
BlueStone Venture PartnersSeries A Extension
FundRxSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 22, 2025

    Secured $3M in grant funding.

  • May 1, 2025

    New location in Brookline, Boston, set to open May 1, 2025.

CND Life Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CND Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CND Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersScottsdale, Arizona
Employee Range124
Year Founded2017
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.